ABSTRACT Plasma exudation is one cardinal factor in airways defence and inflammation. In inflammatory airway diseases such as rhinitis and asthma, however, plama leakage may also have a pathogenetic role. Experimental data from animals indicate that highly sensitive, active, and reversible processes regulate the vascular and mucosal permeability to macromolecules. With the use ofa nasal lavage model for the recovery ofliquids on the mucosal surface the effect ofhistamine on the macromolecular permeability of the airway endothelial-epithelial barriers was studied in normal subjects. The concentrations ofalbumin, kinins, and N-a-fl-tosyl-L-arginine-methyl esterase (TAME) in nasal lavage fluid were measured and nasal symptoms assessed by a scoring technique. The reproducibility of three repeated challenges with 30 minute intervals on the same day was studied in 12 subjects and compared with the same procedure (three challenges) on a different day. Sneezing decreased significantly (p < 0-05) after the first histamine challenge but was maintained thereafter. Otherwise, the mean values for symptoms and for markers of vascular leakage were very similar both for the three challenges in the same session and for the two challenge sessions on a different day. Sneezing, blockage, and secretions were associated with increased concentrations of TAME esterase (maximum 9000 cpm/ml), kinins (I 4 ng/ml), and albumin (0-3 g/1) in lavage fluid. Both the symptoms and the measures of plasma exudation were reversible and reproducible in the three repeat histamine challenges and at two challenge sessions on different days. These findings support the view that non-injurious, active processes regulate the inflammatory flow ofmacromolecules across airways endothelial-epithelial barriers. The present experimental approach would be suitable for studies of the modulatory effects of inflammatory stimulus induced plasma leakage and symptoms in human airways.
Introduction
Plasma exudation has long been known to be a cardinal factor in inflammation, the exuded plasma and its potent peptide products passing through the inflamed epithelial lining of cavity organs to be recovered on the mucosal surface. In inflammatory airway diseases such as rhinitis and asthma, however, a pathogenetic role of plasma leakage has been little emphasised'; in current discussions ofmucosal defence this inflammatory passage of plasma is frequently referred to as a passive leakage across injured mucosal barriers, its role being seen only as a secondary line of defence.2 It has been suggested, for example, that because a dose of histamine induces substantial plasma exudation it is "highly unphysiologic" and less relevant for studies of the pharmacology of airway mucosa.3 This view seems to be at variance with recent experimental findings, which show that highly sensitive, active, and reversible processes regulate vascular and mucosal permeability to macromolecules.i7
A role for exuded plasma proteins and peptides in rhinitis and asthma is supported by a substantial accumulation of data. Plasma exudation tracers sampled at the mucosal surface may be increased under baseline disease conditions in addition to showing a correlation with symptom induction and prevention. In these respects exuded plasma may be a better 13 14 correlate of the disease state than several cellular mediators.''2
We have now used histamine to study how frequently and reproducibly plasma exudation can be induced in human airways. This amine has direct effects on barrier cells,6" is a mediator of allergic rhinitis and asthma,'3 and is widely used as an inhalational agent in studies ofhyperresponsiveness in patients with airways disease.'415 We have applied the challenge to nasal airways as surface liquids can be sampled readily from this area.'4 Adequate techniques are lacking for selective and non-traumatic sampling of the tracheobronchial mucosal fluid.'6 Animal studies have shown that histamine induces plasma leakage in tracheobronchial airways'3 but the possibility that histamine has this activity in nasal mucosa in man has rarely been mentioned.3'7 The present study examined plasma exudation and symptoms occurring in response to a fixed dose of histamine applied to the nasal mucosa at half hour intervals. We also studied the reproducibility of the effects induced by three histamine applications repeated at 30 minute intervals.
Methods

SUBJECTS
Twelve normal subjects (nine male, three female) were recruited, ranging in age from 24 to 42 (mean age 31) years. None had a history of allergic nasal disease or had any nasal complaint at the time of the study. No drugs were allowed during the study. Informed consent was obtained from each individual and the study was approved by the ethics committee of the University of Lund.
NASAL CHALLENGE PROCEDURE Nasal fluid was collected by lavaging the nose with 5 ml aliquots of normal saline (0 9%) instilled into each nostril while the head was flexed backwards 30°f rom the horizontal.'8 This position was maintained for 10 seconds while the subject refrained from Svensson, Baumgarten, Pipkorn, Alkner, Persson breathing and swallowing. On leaning forward the subjects expelled the lavage fluid into a container. Nasal liquids delivered in association with sneezes were added to the appropriate lavage fluid sample. The protocol (fig 1) included three prechallenge lavages with saline to reduce the cell free mediators present initially in nasal secretions to a stable baseline. The fluid from lavages 2 and 3 was discarded. Further lavages were then performed at 10 minute intervals. Immediately after the fifth lavage (at 30 minutes) each nostril was challenged with the diluent used for histamine to control for the delivery system. This was followed by three lavages at 10 minute intervals. Thereafter each nostril was challenged with 0-5 mg histamine hydrochloride in a solution of 0-9% sodium chloride and 0-25% human serum albumin. This was followed by three further lavages at 10 minute intervals. The histamine challenge followed by the three lavages was then repeated twice. Each subject was given the three doses of histamine on two occasions separated by at least a week. The lavage fluid that returned was measured and processed for the chemical analysis described below.
ASSESSMENT OF SYMPTOMS
A symptom questionnaire was given to subjects during the challenge procedure. A five point scale from 0 to 4 (0 = no symptoms, 4 = severe symptoms) was used for assessing nasal stuffiness, nasal secretion, and sneezing.
ANALYTICAL ASSAYS
Kinins were measured by a radioimmunoassay'°sen-sitive to 20 pg/ml with an intraassay coefficient of variation of 5% and an intercoefficient of 10%. N-ax-ftosyl-L-arginine-methyl esterase (TAME) activity was measured by a radiochemical assay essentially as described by Imanari'9 and adapted for the nasal lavage procedure. Albumin was measured with a radioimmunoassay sensitive to 6 25 ng/ml with antialbumin (DAKOPATTS, Copenhagen) and commercial standard (Calbiochem, San Diego, California). Iodination was made with the lactoperoxidase method2' to a specific activity of 2 mCi/nmol. The intraassay coefficient of variation was 5% and the intercoefficient 10%.
STATISTICAL ANALYSES
Statistical evaluation was performed on a microcomputer (Macintosh, Apple Computer, Cupertino, USA) using a software package ('Statview 512 + by Brainpower Inc, Calabasas, California). The measurements that followed the three histamine challenges were used to assess reproducibility on the same day (three observations) and between days (the first observation and the third observation were analysed separately). § 
Results
Data from all 12 subjects who entered the study were challenge, appearing two to six minutes after the challenge. The secretion score had almost returned to baseline by 10 minutes, whereas the blockage score was raised before the second and third histamine provocations. The challenge induced peak responses were nevertheless quite separate and reached the same height (fig 2) . The initial histamine challenge produced more sneezes (p < 0 05) than the second and third challenges, which produced an equal mean sneeze score.
The result from the measurements ofsolutes in nasal secretions are presented in figure 3 . The recovery ofthe instilled lavage fluid was always over 80%. The levels of TAME esterase, kinins and albumin showed a similar pattern to that seen with the nasal symptoms. There was a low baseline TAME esterase activity before the challenge procedure. Each histamine provocation significantly increased the TAME esterase activity to about the same mean peak level. The activity before the second and third histamine challenges was twice the baseline activity before any challenge. Histamine also increased the concentration of kinins and albumin in the lavage samples, but these solutes returned almost to baseline values between the provocations (fig 3) . The coefficient ofvariation for the histamine induced appearance of these solutes in lavage liquids are shown in rhinitis." About 70% of the TAME esterase activity found in lavage fluid obtained after allergen challenge is consistent with the plasma kallikrein-a2 macroglobulin complex, other sources, including mast cell tryptase, being responsible for a lesser part of this activity." Histamine, which does not cause mast cell mediator release, appears to induce TAME esterase activity in nasal lavage fluid through the plasma kallikrein-a2 macroglobulin complex, which is devoid of kininogenase activity.24 Table 3 Correlations* between values obtainedfor symptoms andplasma proteins during thefirst challenge session group
The present limited measurements suggest that unrestricted plasma macromolecular flow into airway liquids has occurred in response to histamine. Molecules from 70 000 (albumin) to 900 000 daltons (a2 macroglobulin) have passed across the endothelialepithelial linings, which normally provide a tight barrier at least to macromolecular movement.6" Histamine induced leakage may therefore have been a bulk flow of plasma proteins across the vascular wall25 and mucosal epithelial lining. Widely varying protein systems would thus come in contact with negatively charged membranes and surfaces. The ensuing activation ofplasma systems was in this study exemplified by kinin formation. Conceivably complement, coagulation, and other plasma systems also would have been activated, but this remains to be studied in detail.
This study showed consistent plasma leakage in response to an inflammatory mediator applied repeatedly at half hour intervals. Not only was the histamine induced plasma leakage rapidly induced and rapidly reversible but the airway vascular and mucosal responsiveness was unchanged when the challenge was repeated after 30 minutes. Further applications of histamine beyond three might have continued to produce consistent plasma leaks, as in animal experimental systems, where the microvascular barrier has been shown to respond reversibly and consistently to histamine applications every 30 minutes.726 Little is known about corresponding mucosal barrier mechanisms.
The present method measures the sum of macromolecular permeability across the microvascular endothelium and the mucosal epithelium. Macromolecular flow across both barriers is clearly increased promptly with the application of histamine. We cannot tell from the present data whether the epithelial permeability has the same time courses in change in permeability as the vascular barrier or whether the epithelium remained permeable after the initial histamine challenge. The epithelial passage of plasma is an important clearance route, reducing the tendency of mucosal oedema formation.'2 Epithelial permeability to exuded plasma may be different from the permeability responsible for absorption of luminal macromolecules into airway tissue. Whether the increased mucosal permeability we have studied is bidirectional remains to be examined. Methacholine differs from histamine in not causing plasma exudation in nasal and tracheobronchial airways.32' This suggests that histamine induced neural cholinergic activation may not have contributed to the plasma exudation in this study. Tachykinergic nerves may also not have contributed since tachykinins, which act as potent inflammatory agents in guinea pigs, may not act thus in man.2728 Several pieces of experimental evidence, including receptor localisation, suggest that histamine exerts its effect directly on the vascular permeability regulating endothelial cells.47 The microvessels that consistently respond to an inflammatory stimulus such as histamine are the postcapillary venules.4 72 The histamine induced venular permeability is known as an active endothelial mechanism, perhaps a contractional event, that is under physiological and pharmacological control. Clearly the present observation of histamine induced plasma leakage in human airways is consistent with the idea that non-injurious mucosal processes are concerned in the exudation of plasma.
The symptoms induced by histamine may be due to direct effects on target cells by plasma exudation, but may also in part be produced indirectly via complex neural and non-neural interactions. Histamine stimulates afferent rapidly adapting receptors and C fibre nerve endings,' both of which may play a part in sneezing (and coughing). Exuded plasma products such as kinins also stimulate these afferent mechanisms' and might have participated in the sneeze inducing action of topical histamine. Sneezing was most pronounced with the first histamine challenge (fig 2) . The second and third histamine applications, however, had about equal effects, indicating that tachyphylaxis of the sneezing mechanism was limited. This is in contrast to observations on repeated allergen provocations (roughly 40 minute intervals), where the sneezing response was substantially reduced.0 With frequently repeated allergen provocations we cannot expect consistent responses in terms ofchange either in biochemical variables or in symptoms because allergen induced effects have such variable time courses of monophasic and biphasic responses.3" ' Allergen provocations may thus induce alterations in baseline values and in mucosal sensitivity to further provocations. Allergen induced plasma exudation is different in its characteristics from the histamine induced plasma exudation in our study.
Both the symptoms and the measures of plasma exudation were reasonably reproducible in repeat challenges with histamine and at repeat sessions of such challenges. This suggests that the present experimental approach is suitable for studies of modulatory effects of inflammatory stimulus induced plasma leakage and symptoms in human airways.
This study was supported in part by grants from the Swedish Medical Research Council (project 8308), the medical faculty of the University of Lund, and AB Draco, Lund. References
